Literature DB >> 8083377

Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism.

B Dahlbäck1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8083377      PMCID： PMC295127          DOI： 10.1172/JCI117458

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  33 in total

Review 1.  The coagulation cascade: initiation, maintenance, and regulation.

Authors:  E W Davie; K Fujikawa; W Kisiel
Journal:  Biochemistry       Date:  1991-10-29       Impact factor: 3.162

2.  Bovine coagulation factor V visualized with electron microscopy. Ultrastructure of the isolated activated forms and of the activation fragments.

Authors:  B Dahlbäck
Journal:  J Biol Chem       Date:  1986-07-15       Impact factor: 5.157

3.  Identification of a new protein involved in the regulation of the anticoagulant activity of activated protein C. Protein S-binding protein.

Authors:  F J Walker
Journal:  J Biol Chem       Date:  1986-08-15       Impact factor: 5.157

4.  The binding of activated protein C to factors V and Va.

Authors:  S Krishnaswamy; E B Williams; K G Mann
Journal:  J Biol Chem       Date:  1986-07-25       Impact factor: 5.157

5.  Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa.

Authors:  L Shen; B Dahlbäck
Journal:  J Biol Chem       Date:  1994-07-22       Impact factor: 5.157

6.  Effects of thrombomodulin and coagulation Factor Va-light chain on protein C activation in vitro.

Authors:  H H Salem; N L Esmon; C T Esmon; P W Majerus
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

7.  Inactivation of human coagulation factor V by activated protein C.

Authors:  K Suzuki; J Stenflo; B Dahlbäck; B Teodorsson
Journal:  J Biol Chem       Date:  1983-02-10       Impact factor: 5.157

8.  Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.

Authors:  B Dahlbäck; M Carlsson; P J Svensson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

9.  Incidence and clinical characteristics of hereditary disorders associated with venous thrombosis.

Authors:  M D Tabernero; J F Tomas; I Alberca; A Orfao; A Lopez Borrasca; V Vicente
Journal:  Am J Hematol       Date:  1991-04       Impact factor: 10.047

Review 10.  Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system.

Authors:  B Dahlbäck
Journal:  Thromb Haemost       Date:  1991-07-12       Impact factor: 5.249
View more
  16 in total

1.  Incidence of factor V Leiden in patients with acute myocardial infarction.

Authors:  M S Gowda; M L Zucker; J L Vacek; W L Carriger; D L Van Laeys; J M Rachel; B D Strope
Journal:  J Thromb Thrombolysis       Date:  2000-01       Impact factor: 2.300

2.  Activated protein C and retinal vein occlusion.

Authors:  B J Hunt
Journal:  Br J Ophthalmol       Date:  1996-03       Impact factor: 4.638

3.  Retinal arterial occlusion associated with resistance to activated protein C.

Authors:  S Vignes; B Wechsler; C Elmaleh; N Cassoux; M H Horellou; P Godeau
Journal:  Br J Ophthalmol       Date:  1996-12       Impact factor: 4.638

4.  Population study of the G1691A mutation (R506Q, FV Leiden) in the human factor V gene that is associated with resistance to activated protein C.

Authors:  A Braun; B Müller; A A Rosche
Journal:  Hum Genet       Date:  1996-02       Impact factor: 4.132

5.  Benign intracranial hypertension associated to blood coagulation derangements.

Authors:  Domenico De Lucia; Marisanta Napolitano; Pierpaolo Di Micco; Alferio Niglio; Andrea Fontanella; Giuseppe Di lorio
Journal:  Thromb J       Date:  2006-12-24

6.  Multiple simultaneous venous and arterial thromboses in a patient with factor V Leiden disorder: Detection by multislice computed tomography.

Authors:  Bige Sayin; Tuğba Durakoğlugil; İlkay Akmangit; Murtaza Emre Durakoğlugil; Murat Vural; Eda Elverici
Journal:  Interv Med Appl Sci       Date:  2015-03-20

Review 7.  Factor V Leiden: should we screen oral contraceptive users and pregnant women?

Authors:  J P Vandenbroucke; F J van der Meer; F M Helmerhorst; F R Rosendaal
Journal:  BMJ       Date:  1996-11-02

8.  SV-IV Peptide1-16 reduces coagulant power in normal Factor V and Factor V Leiden.

Authors:  Biagio Di Micco; Marilena Lepretti; Lidia Rota; Ilaria Quaglia; Paola Ferrazzi; Gianluca Di Micco; Pierpaolo Di Micco
Journal:  J Transl Med       Date:  2007-12-21       Impact factor: 5.531

Review 9.  Human gene mutation in pathology and evolution.

Authors:  D N Cooper
Journal:  J Inherit Metab Dis       Date:  2002-05       Impact factor: 4.982

10.  Population differences in the frequency of the factor V Leiden variant among people with clinically symptomatic protein C deficiency.

Authors:  P J Hallam; D S Millar; M Krawczak; V V Kakkar; D N Cooper
Journal:  J Med Genet       Date:  1995-07       Impact factor: 6.318
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.